Informationen: Dieses ist nicht die aktuellste Version des Datenmodells. Eine Versionsübersicht finden Sie links unter Versionen. Die aktuellste Version finden Sie hier.
Informationen:
Fehler:
ID
4756
Beschreibung
Six Months Efficacy and Safety of Aliskiren Therapy on Top of Standard Therapy, on Morbidity and Mortality in Patients With Acute Decompensated Heart Failure (ASTRONAUT) See http://clinicaltrials.gov/ct2/show/record/NCT00894387
Link
http://clinicaltrials.gov/ct2/show/record/NCT00894387
Stichworte
Versionen (3)
- 18.11.11 18.11.11 -
- 26.03.14 26.03.14 - Martin Dugas
- 13.04.14 13.04.14 - Julian Varghese
Hochgeladen am
26. März 2014
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY-NC 3.0 Legacy
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Eligibility NCT00894387 Heart Failure
Eligibility Heart failure NCT00894387
- StudyEvent: Eligibility
Ähnliche Modelle
Eligibility Heart failure NCT00894387
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Heart failure
Item
primary diagnosis of worsening heart failure
boolean
C0018801 (UMLS CUI-1)
Age
Item
age >= 18 years
boolean
Heart failure signs and symptoms
Item
acute heart failure symptoms (dyspnea or fatigability - NYHA Class III-IV) and signs of fluid overload (i.e., jugular venous distension, edema or positive rales auscultation or pulmonary congestion on chest x-ray) at the time of hospitalization
boolean
C0851638 (UMLS CUI-1)
LVEF
Item
LVEF less than 40% (measured within the last 6 months)
boolean
C0232174 (UMLS CUI-1)
Hospitalization
Item
Hospitalization for ADHF and remain "stabilized" for at least 6 hours (defined as SBP >= 110 mm Hg after acute decompensated episode) and did not receive IV vasodilators (other than nitrates) and/or IV inotropic drugs at anytime from ADHF presentation to time of randomization
boolean
C0019993 (UMLS CUI-1)
BNP
Item
Elevated BNP at Visit 1 or at randomization (BNP >= 400 pg/ml)
boolean
C1095989 (UMLS CUI-1)
History of heart failure
Item
Patients with a history of chronic heart failure on standard therapy defined as requiring HF treatment for at least 30 days before the current hospitalization (NYHA Class II - IV).
boolean
C0455531 (UMLS CUI-1)
Prior Therapy
Item
Patients that required any use of IV vasodilators (except nitrates), and/or any IV inotropic therapy from the time of presentation for worsening HF to randomization.
boolean
C1514463 (UMLS CUI-1)
Concomitant medication ongoing
Item
Concomitant use of ACEI and ARB at randomization.
boolean
C2826666 (UMLS CUI-1)
Pulmonary disease
Item
Right heart failure due to pulmonary disease.
boolean
C0024115 (UMLS CUI-1)
Cardiomyopathy
Item
Diagnosis of postpartum cardiomyopathy.
boolean
CL411823 (UMLS CUI-1)
Myocardial infarction
Item
Myocardial infarction or cardiac surgery, including percutaneous transluminal coronary angioplasty (PTCA), within past 3 months.
boolean
C0027051 (UMLS CUI-1)
Heart transplantation
Item
Patients with a history of heart transplant or who are on a transplant list.
boolean
C0018823 (UMLS CUI-1)
Coronary artery disease
Item
Unstable angina or coronary artery disease likely to require coronary artery bypass graft (CABG) or PTCA before randomization.
boolean
C0010068 (UMLS CUI-1)